Subsequent experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy

Abstract

PurposeEpilepsy surgery is the most successful method of treating medically unresponsive epilepsy, but carries a risk of morbidity. PET/MR is an emerging technique that increases detection of focal lesions whose resection may result in symptom remission. MethodsRetrospective review of 74 focal epilepsy patients over a period of 3 years who had a PET/MR was performed following IRB permission and informed consent. 27 patients underwent surgery or RNS (responsive neurostimulator) placement. ResultsHybrid PET-MR identified new anatomic or functional lesions in 10 patients not identified with standalone 3 T MR. Of the 27 patients who underwent focal surgery (19) or RNS placement (8), 24 showed improvement (Engel’s I-III), 2 did not (Engel’s IV), and one had an RNS explanted due to infection. MR and PET were read by 2 separate neuroradiologists and nuclear medicine physicians, respectively. Modalities were evaluated in terms of ability to detect the correct lobe and side for a focal lesion whose resection improved symptoms. Prior standalone MR exhibited 71–77% sensitivity and 0% specificity (as there were only 2 nonresponders), MR associated with PET/MR had 68–71% sensitivity and 0–50% specificity (depending on whether a lesion was seen on one of the nonresponders), and PET had 68–71% sensitivity and 25–33% specificity. Using either PET or MR to identify a focal lesion, PET/MR had sensitivity of 78–82% and specificity 0–50%. ConclusionsPET-MR provides additional sensitivity when used as two combined modalities for detecting possible epileptic foci.